🏢 官网IRBMRNCodex · 实盘不做把握 9/10
北京时间·🕒 发布 21:00:00(美东 09:00)·⟳ 抓取 21:04:39 +4m39s·⚡ 决策 07-30 21:05:26 +47s·89.0 天前
BioMarin宣布将于8月6日召开二季度业绩电话会
这只是例行财报电话会和网络直播安排，未披露业绩数据、指引变化、产品进展或监管结果。
📄 原文BMRN↗ 原文
SAN RAFAEL, Calif. , July 30, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Ale…
不做 BioMarin Pharmaceutical（BMRN.US）
例行二季度业绩电话会预告，没有业绩数字、指引变化或产品监管进展，无法形成同向可交易 edge。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-07-30 · 扩散 low · price-in 风险 high ↗
关键理由
- 这只是例行财报电话会和网络直播安排，未披露业绩数据、指引变化、产品进展或监管结果。
主要风险
- 后续真正的二季度业绩和业务更新需等8月6日披露后重新研判。
原文全文
展开原文 · 1,848 字
SAN RAFAEL, Calif.
,
July 30, 2026
/PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will host a conference call and webcast on Thursday, August 6, 2026, at 4:30 p.m. ET to discuss second quarter 2026 financial results and provide a general business update.
Dial-in Number
U.S. / Canada Dial-in Number: 800-715-9871
International Dial-in Number: 646-307-1963
Conference Call ID: 3551298
U.S. / Canada Replay Dial-in Number: 800-770-2030
International Replay Dial-in Number: 609-800-9909
Playback ID: 3551298
Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website,
https://investors.biomarin.com/
. A replay of the call will be archived on the site for one week following the call.
About BioMarin
BioMarin is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Founded in 1997, the San Rafael, California-based company has a proven track record of innovation, with nine commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin seeks to unleash the full potential of genetic science by pursuing category-defining medicines that have a profound impact on patients. To learn more, please visit
www.biomarin.com
.
Contacts:
Investors
Media
Traci McCarty
Marni Kottle
BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
(415) 455-7558
(650) 374-2803
View original content to download multimedia:
https://www.prnewswire.com/news-releases/biomarin-to-host-second-quarter-2026-financial-results-conference-call-and-webcast-on-thursday-august-6-2026-at-430pm-et-302838363.html
SOURCE BioMarin Pharmaceutical Inc.
,
July 30, 2026
/PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will host a conference call and webcast on Thursday, August 6, 2026, at 4:30 p.m. ET to discuss second quarter 2026 financial results and provide a general business update.
Dial-in Number
U.S. / Canada Dial-in Number: 800-715-9871
International Dial-in Number: 646-307-1963
Conference Call ID: 3551298
U.S. / Canada Replay Dial-in Number: 800-770-2030
International Replay Dial-in Number: 609-800-9909
Playback ID: 3551298
Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website,
https://investors.biomarin.com/
. A replay of the call will be archived on the site for one week following the call.
About BioMarin
BioMarin is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Founded in 1997, the San Rafael, California-based company has a proven track record of innovation, with nine commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin seeks to unleash the full potential of genetic science by pursuing category-defining medicines that have a profound impact on patients. To learn more, please visit
www.biomarin.com
.
Contacts:
Investors
Media
Traci McCarty
Marni Kottle
BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
(415) 455-7558
(650) 374-2803
View original content to download multimedia:
https://www.prnewswire.com/news-releases/biomarin-to-host-second-quarter-2026-financial-results-conference-call-and-webcast-on-thursday-august-6-2026-at-430pm-et-302838363.html
SOURCE BioMarin Pharmaceutical Inc.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。